238
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluation

Thalidomide in multiple myeloma

Pages 195-213 | Published online: 24 Jan 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Iris Breitkreutz & Kenneth C Anderson. (2008) Thalidomide in multiple myeloma – clinical trials and aspects of drug metabolism and toxicity. Expert Opinion on Drug Metabolism & Toxicology 4:7, pages 973-985.
Read now

Articles from other publishers (12)

Annalisa Mercurio, Lucy Sharples, Filomena Corbo, Carlo Franchini, Angelo Vacca, Alessia Catalano, Alessia Carocci, Roger D. Kamm, Andrea Pavesi & Giulia Adriani. (2019) Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos. Frontiers in Pharmacology 10.
Crossref
Benjamin E. Blass. (2017) Editorial for Cancer Virtual Issue. ACS Medicinal Chemistry Letters 8:12, pages 1205-1207.
Crossref
Kuldeep Dhama, Mani Saminathan, Siju Susan Jacob, Mithilesh Singh, K. Karthik, Amarpal .Ruchi Tiwari, Lakshmi Tulasi Sunkara, Yashpal Singh Malik & Raj Kumar Singh. (2015) Effect of Immunomodulation and Immunomodulatory Agents on Health with some Bioactive Principles, Modes of Action and Potent Biomedical Applications. International Journal of Pharmacology 11:4, pages 253-290.
Crossref
R. García‐Sanz, T.J. González‐López, L. Vázquez, G. Hermida, I.F. Graciani & J.F. San Miguel. (2010) The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin’s lymphoma. European Journal of Haematology 84:3, pages 266-270.
Crossref
Nobuhiro Ooba, Tsugumichi Sato, Hikaru Watanabe & Kiyoshi Kubota. (2010) Resolving a Double Standard for Risk Management of Thalidomide. Drug Safety 33:1, pages 35-45.
Crossref
Scott G. Stewart, Carlos J. Braun, Marta E. Polomska, Mahdad Karimi, Lawrence J. Abraham & Keith A. Stubbs. (2010) Efforts toward elucidating Thalidomide’s molecular target: an expedient synthesis of the first Thalidomide biotin analogue. Organic & Biomolecular Chemistry 8:18, pages 4059.
Crossref
Todd Zimmerman. (2009) Immunomodulatory agents in oncology. Update on Cancer Therapeutics 3:4, pages 170-181.
Crossref
William Bensinger. (2008) Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Drugs. Journal of Clinical Oncology 26:3, pages 480-492.
Crossref
Paul G. Richardson, Constantine Mitsiades, Robert Schlossman, Nikhil Munshi & Kenneth Anderson. (2007) New Drugs for Myeloma. The Oncologist 12:6, pages 664-689.
Crossref
Ramón García-Sanz, María Victoria Mateos & Jesús Fernando San Miguel. (2007) Mieloma múltiple. Medicina Clínica 129:3, pages 104-115.
Crossref
Jack Hirsh. (2007) Risk of Thrombosis With Lenalidomide and Its Prevention With Aspirin. Chest 131:1, pages 275-277.
Crossref
. (2006) Current Awareness in Hematological Oncology. Hematological Oncology 24:3, pages 166-173.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.